Advanced Medical Solutions Grp PLC Holding(s) in Company (1236O)
November 02 2016 - 4:58AM
UK Regulatory
TIDMAMS TIDMAV.
RNS Number : 1236O
Advanced Medical Solutions Grp PLC
02 November 2016
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
-----------------------------------------------------------------------------------------------------------
1. Identity of the issuer or Advanced Medical Solutions
the underlying issuer Group plc
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- ----------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-----------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
---------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
---------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
---------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
---------------------------------------------------------------------------------------------------------
Other (please CHANGE TO THE NUMBER OF VOTING RIGHTS
specify): IN ISSUE
----------------------------------------------------------- --------------------------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- --------------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
BNY Norwich Union Nominees
Limited 447,817*
Chase (GA Group) Nominees
Limited 7,082,143*
Chase Nominees Limited 162,670*
Available on Request 34,875*
* denotes direct interest
------------------------------------------------------------- --------------------------------------------
5. Date of the transaction 31 October 2016
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- --------------------------------------------
6. Date on which issuer 01 November 2016
notified:
------------------------------------------------------------- --------------------------------------------
7. Threshold(s) that is/are 4% to 3% Change at Direct
crossed or Interest Level (Box 8A + 8B)
reached: (vi, vii)
------------------------------------------------------------- --------------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------- --------------------------- ----------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
--------------- -------------- ----------- ----------- -------------------------- -----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- -------------- ----------- ----------- ---------- -------------- ------- --------------
Ordinary
Shares
Not Not
GB0004536594 8,460,451* 8,460,451* 7,727,505 7,727,505 Disclosable 3.672% Disclosable
-------------- ----------- ----------- ---------- -------------- ------- --------------
* Includes Right to Recall Loaned Shares (1,769,027)
--------------------------------------------------------------------------------------------------------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
--------------- -------------- ------------------------ -------------------------- -----------------------
RIGHT TO 689,263*
RECALL
LOANED SHARES N/A N/A *Direct Interest 0.327%
--------------- -------------- ------------------------ -------------------------- -----------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
8,416,768 3.999%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited and Friends Provident
International Limited, with the following chain of controlled
undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Life Holdings UK Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Friends Life FPG Limited (wholly owned subsidiary of
Aviva Life Holdings UK Limited)
* Friends Life FPL Limited (wholly owned subsidiary of
Friends Life FPG Limited)
* Friends Life Limited (wholly owned subsidiary of
Friends Life FPL Limited)
* Friends Life and Pensions Limited (wholly owned
subsidiary of Friends Life Limited)
* Friends Provident International Limited (wholly owned
subsidiary of Friends Life and Pensions Limited)
---------------------------------------------------------------
Proxy Voting:
-------------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
------------------------------------- ----------------------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------- ----------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------- ----------------------------------
13. Additional information: Figures are based on a total
number of voting rights of
210,453,923 as per the Company's
Total Voting Rights Announcement
of 31 October 2016.
------------------------------------- ----------------------------------
14. Contact name: Neil Whittaker, Aviva plc
------------------------------------- ----------------------------------
15. Contact telephone number: 01603 684420
------------------------------------- ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUUVWRNSAARRA
(END) Dow Jones Newswires
November 02, 2016 04:58 ET (08:58 GMT)